PATH | VRL
Menu
We've moved! Same resources, new address: vaccineresources.org

Find resources

Total results with these characteristics: 851

Resource type: Peer-reviewed journal

Page 41 of 43
An Update on Vaccination Against Group B Streptococcus

This article, published in Expert Review of Vaccines, examines the vaccine development pipeline for group B Streptococcus (GBS). The authors note that a number of candidates have the potential to be successful, but that there are issues still to be …

Author: Heath PT

Publication date: 2011

Updated Estimation of the Impact of a Japanese Encephalitis Immunization Program With Live, Attenuated SA 14-14-2 Vaccine in Nepal

This article, published in PLoS Neglected Tropical Diseases, describes the impact of the Japanese encephalitis (JE) immunization program in Nepal using SA 14-14-2 JE vaccine from 2006 to 2011. A previous assessment after the initial program …

Author: Upreti SR, Lindsey NP, Bohara R, et al.

Publication date: 2017

Uptake of the Human Papillomavirus Vaccine in Kenya: Testing the Health Belief Model Through Pathway Modeling on Cohort Data

This article, published in Globalization and Health, reports the results of a study that investigated the utility of the Health Belief Model (HBM) in predicting uptake of human papillomavirus (HPV) vaccine in Kenya. The data demonstrated that …

Author: Vermandere H, van Stam M-A, Naanyu V, Michielsen K, Degomme O, Oort F

Publication date: 2016

Use of Quantitative Molecular Diagnostic Methods to Identify Causes of Diarrhoea in Children: A Reanalysis of the GEMS Case-Control Study

This article, published in The Lancet, reports the results of a study that reanalyzed the Global Enteric Multicenter Study data to identify the leading causes of diarrhea in children under five years of age in sub-Saharan Africa and south Asia. The …

Author: Liu J, Platts-Mills JA, Juma J, et al.

Publication date: 2016

Using Solar-Powered Refrigeration for Vaccine Storage Where Other Sources of Reliable Electricity are Inadequate or Costly

Large areas of many developing countries have no grid electricity, which is a serious challenge that threatens the continuity of the vaccine cold chain. This article, published in Vaccine, highlights some lessons learned with solar-powered …

Author: McCarney S, Robertson J, Arnaud J, Lorenson K, Lloyd J

Publication date: 2013

Vaccination Against Enterotoxigenic Escherichia coli, A Cause of Travelers' Diarrhea

This review, published in The Journal of Travel Medicine, focuses on the strategies behind development and potential use of currently available vaccines and vaccine candidates against enterotoxigenic Escherichia coli (ETEC) infection. As …

Author: Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N

Publication date: 2005

Vaccination Against Pneumococcus in West Africa: Perspectives and Prospects

This article, published in the International Journal of General Medicine, provides epidemiological insights into pneumococcal conjugate vaccines in West Africa based on the prevailing pneumococcal serotypes in the subregion. The study covered …

Author: Donkor ES, Dayie NT, Badoe EV

Publication date: 2013

Vaccination Against Respiratory Syncytial Virus in Pregnancy: A Suitable Tool to Combat Global Infant Morbidity and Mortality?

This article, published in The Lancet Infectious Diseases, describes the epidemiological and immunological background of respiratory syncytial virus (RSV) infection and the pipeline of RSV vaccines in development. It discusses the potential for …

Author: Saso A, Kampmann B

Publication date: 2016

Vaccine

A peer reviewed journal published by Elsevier. The tables of contents and abstracts are online. Archived editions may be searched by keyword and author. Users may register at this site for free Tables of Contents to be sent via email.

Author: Elsevier

Vaccine Advance-Purchase Agreements for Low-Income Countries: Practical Issues

This article, published in Health Affairs, considers the practical economic and legal arrangements for advance-purchase commitments to increase incentives for the development and production of vaccines for diseases concentrated in low-income …

Author: Berndt ER, Hurvitz JA

Publication date: 2005

The Vaccine and Cervical Cancer Screen (VACCS) Project: Acceptance of Human Papillomavirus Vaccination in a School-Based Programme in Two Provinces of South Africa

This article, published in the South African Medical Journal, investigated the acceptance of a school-based human papillomavirus (HPV) vaccination delivery strategy. The results demonstrated that HPV vaccination is practical and safe in South …

Author: Botha MH, van der Merwe FH, Snyman LC, Dreyer G.

Publication date: 2015

A Vaccine Cold Chain Freezing Study in PNG Highlights Technology Needs for Hot Climate Countries

Emphasis has long been placed on keeping vaccines cold, with less attention devoted to prevention of vaccine damage from freezing. Published reports and field evidence now demonstrate that freezing of vaccines in the cold chain is commonplace, …

Author: Wirkas T, Toikilik S, Miller N, Morgan C, Clements CJ

Publication date: 2006

Vaccine Discovery and Translation of New Vaccine Technology

An unprecedented increase in new vaccine development has occurred over the past three decades. This article, published in The Lancet, discusses new methods of discovery, such as reverse vaccinology, structural biology, and systems biology, which …

Author: Rappuoli R, Black S, Lambert PH

Publication date: 2011

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

This article, published in the New England Journal of Medicine, describes a multinational, Phase 3, observer-blinded study evaluating the efficacy of quadrivalent influenza vaccine (QIV) among children three to eight years of age. From the study …

Author: Jain VK, Rivera L, Zama Khalequ, et al.

Publication date: 2013

The Vaccine Paradox

This article, which serves as an introduction to The Lancet's series New Decade of Vaccines, discusses the opportunity that the vaccine community has to rewrite the terms of engagement between vaccines and communities threatened with …

Author: Horton R, Das P

Publication date: 2011

Vaccine Presentation and Packaging Advisory Group: A Forum for Reaching Consensus on Vaccine Product Attributes

Published in the Bulletin of the World Health Organization, this article describes a novel approach to improving vaccine design and presentation in order to reach all children with lifesaving vaccines. The Vaccine Presentation and Packaging Advisory …

Author: Mansoor OD, Kristensen D, Meek A, et al.

Publication date: 2012

Vaccine Production, Distribution, Access, and Uptake

For human vaccines to be available on a global scale, complex production methods, meticulous quality control, and reliable distribution channels are needed to ensure that the products are potent and effective at the point of use. In this article, …

Author: Smith J, Lipsitch M, Almond JW

Publication date: 2011

Vaccine Stabilization: Research, Commercialization, and Potential Impact

This article, published in Vaccine, discusses the challenges of different approaches to developing and producing thermostable vaccines. Topics include the technical feasibility of improving vaccine thermostability and thus vaccine effectiveness …

Author: Kristensen D, Chen D, Cummings R

Publication date: 2011

Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011

This article, published in PLoS Neglected Tropical Diseases, reviews and discusses strategies for the promotion and expansion of vaccination programs to reduce the incidence of Japanese encephalitis throughout China and Asia. It discusses the …

Author: Gao X, Li X, Li M, et al.

Publication date: 2014

Vaccine Vial Stopper Performance for Fractional Dose Delivery of Vaccines

This article, published in Human Vaccines & Immunotherapeutics, examines the performance of three types of vaccine vial stopper used in World Health Organization (WHO)-prequalified inactivated poliovirus vaccine (IPV) and yellow fever vaccine …

Author: Jarrahian C, Myers D, Creelman B, Saxon E, Zehrung D

Publication date: 2017

Page 41 of 43